Machine Dreams

How This Biotech Founder Studies Breast Milk To Design Unique Therapeutics

19:50

Most AI drug discovery companies fail in clinical trials. Maolac’s success rate? 10 out of 10.

In this episode of Machine Dreams, CEO Maya Ashkenazi Otmazgin explains how her company uses “protein intelligence” to reverse-engineer breast milk’s biological playbook, designing therapeutics that mimic what nature already perfected.

We discuss why biological data is scarce, how Maolac compresses…